CVS Health Co. (NYSE:CVS) SVP James David Clark Sells 7,513 Shares

CVS Health Co. (NYSE:CVS - Get Free Report) SVP James David Clark sold 7,513 shares of the stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the transaction, the senior vice president now owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

CVS Health Stock Up 1.7 %

Shares of NYSE CVS traded up $1.09 during mid-day trading on Friday, reaching $66.34. 10,082,148 shares of the company's stock traded hands, compared to its average volume of 11,965,158. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The stock has a market cap of $83.64 billion, a P/E ratio of 18.12, a PEG ratio of 0.98 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The business has a 50-day simple moving average of $56.42 and a 200 day simple moving average of $56.73.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, analysts expect that CVS Health Co. will post 5.89 EPS for the current fiscal year.

Remove Ads

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were paid a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.01%. CVS Health's payout ratio is 72.68%.

Institutional Trading of CVS Health

Institutional investors and hedge funds have recently made changes to their positions in the company. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the 3rd quarter worth approximately $25,000. Legacy Investment Solutions LLC bought a new position in CVS Health in the 3rd quarter valued at $31,000. Ridgewood Investments LLC raised its stake in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC purchased a new position in shares of CVS Health in the 4th quarter worth about $28,000. Finally, RPg Family Wealth Advisory LLC bought a new position in CVS Health during the third quarter valued at about $40,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CVS. JPMorgan Chase & Co. upped their target price on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research report on Tuesday, February 18th. Barclays raised their target price on shares of CVS Health from $71.00 to $73.00 and gave the company an "overweight" rating in a report on Thursday, February 13th. StockNews.com upgraded shares of CVS Health from a "sell" rating to a "hold" rating in a research report on Thursday, February 13th. Leerink Partners upgraded CVS Health from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $55.00 to $75.00 in a research note on Thursday, February 13th. Finally, Leerink Partnrs upgraded CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, February 12th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $69.83.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.